(Q40810861)

23 September 2017

In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2. (English)

1 reference

23 September 2017

neoplastic invasiveness

1 reference

1 reference

Lakka SS

1

1 reference

23 September 2017

Konduri SD

2

1 reference

23 September 2017

Mohanam S

3

1 reference

23 September 2017

Nicolson GL

4

1 reference

23 September 2017

Rao JS

5

1 reference

23 September 2017

1 January 2000

1 reference

Clinical & Experimental Metastasis

23 September 2017

1 reference

23 September 2017

18

1 reference

23 September 2017

3

1 reference

23 September 2017

239-244

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1006755223357

23 September 2017

0 references

cites work

Lack of plasminogen activator inhibitor-1 effect in a transgenic mouse model of metastatic melanoma

1 reference

12 December 2020

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

12 December 2020

Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis

1 reference

12 December 2020

Cancer cells overexpress mRNA of urokinase-type plasminogen activator, its receptor and inhibitors in human non-small-cell lung cancer tissue: analysis by Northern blotting and in situ hybridization

1 reference

12 December 2020

Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2.

1 reference

12 December 2020

Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro.

1 reference

12 December 2020

Expression of tissue factor correlates with grade of malignancy in human glioma.

1 reference

12 December 2020

Tissue factor-dependent vascular endothelial growth factor production by human fibroblasts in response to activated factor VII.

1 reference

12 December 2020

Autocrine saturation of pro-urokinase receptors on human A431 cells.

1 reference

12 December 2020

Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2

1 reference

12 December 2020

Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis

1 reference

12 December 2020

Recombinant human tissue factor pathway inhibitor as a possible anticoagulant targeting hepatic sinusoidal walls

1 reference

12 December 2020

Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo

1 reference

12 December 2020

The plasminogen activation system and its role in lung cancer. A review

1 reference

12 December 2020

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

1 reference

12 December 2020

Multiple secretion of matrix serine proteinases by human gastric carcinoma cell lines

1 reference

12 December 2020

HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI.

1 reference

12 December 2020

In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease

1 reference

12 December 2020

The plasminogen-plasmin system in malignancy

1 reference

12 December 2020

Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor

1 reference

12 December 2020

Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody.

1 reference

12 December 2020

Biology and biochemistry of proteinases in tumor invasion.

1 reference

12 December 2020

Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation

1 reference

12 December 2020

cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: identification as placental protein 5 and tissue factor pathway inhibitor-2.

1 reference

12 December 2020

Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer.

1 reference

12 December 2020

Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor

1 reference

12 December 2020

Novel extracellular matrix-associated serine proteinase inhibitors from human skin fibroblasts

1 reference

12 December 2020

Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue

1 reference

12 December 2020

Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor

1 reference

12 December 2020

Plasminogen activators, tissue degradation, and cancer

1 reference

12 December 2020

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

12 December 2020

The angiogenic effect of tissue factor on tumors and wounds

1 reference

12 December 2020

Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs

1 reference

12 December 2020

Identification of one- and two-chain forms of trypsinogen 1 produced by a human gastric adenocarcinoma cell line

1 reference

12 December 2020

Assignment of the human PP5/TFPI-2 gene to 7q22 by FISH and PCR-based human/rodent cell hybrid mapping panel analysis

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1006755223357

1 reference

Dimensions Publication ID

23 September 2017

0 references

1 reference